RxDoctor Payments Data

Brooke Tuttle, APRN

Family · Provo, UTNPI 1871014159

Payments from drug & device makers

$3,188in general payments, 2019–2025

Across 207 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$250
  • Otsuka America Pharmaceutical, Inc.$217
  • Pfizer$190
  • Astellas Pharma US Inc$176
  • Lilly USA, LLC$151
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,188100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,188 in reported general payments places this provider in the 85th percentile of 1,460 family providers in Utah.

See all family providers in Utah

Medicare billing

Part B allowed, 2024
$11,486
Medicare patients
47
Services billed
220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$20,225
Levothyroxine Sodium60$396
Estradiol15$283
Omeprazole20$244
Methylprednisolone15$135
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$105
Metformin Hcl ErMetformin Hcl13$89
Atorvastatin Calcium16$87
Rosuvastatin Calcium11$75
Fluconazole15$62
Azithromycin19$56
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$42
Lisinopril12$39
Citalopram HbrCitalopram Hydrobromide11$36
Amlodipine Besylate11$36

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$250$20,22517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,460 family providers in Utah.

Other family in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →